A collage photo of Novartis and Dren Bio
Jul 28, 2024, 08:50
Novartis collaborates with Dren Bio to discover and advance novel antibody-based immune cell engagers
Fiona Hamilton Marshall, President of the Novartis Institute for BioMedical Research, shared on LinkedIn:
“I’m pleased to share that Novartis has entered into a collaboration agreement with Dren Bio to discover and advance novel antibody-based immune cell engagers for certain cancers.
We look forward to working with the Dren Bio team on this effort, which builds on our expertise in immuno-oncology and biologics and complements the wide range of modalities and approaches.
Novartis researchers are leveraging to bring forward new therapeutic options for patients living with cancer.”
Additional information.
Source: Fiona Hamilton Marshall/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 17, 2024, 01:14
Nov 17, 2024, 01:10
Nov 17, 2024, 01:05
Nov 17, 2024, 01:04
Nov 17, 2024, 00:47
Nov 17, 2024, 00:42